menu
More than 65 industry players across the world are presently engaged in evaluating the clinical applications of over 180
Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active

Over time, extensive R&D on the potential healthbenefits of cannabis, have enabled medical researchers to identify a number ofpharmacologically active ingredients that offer clinical benefit, minus theaddictive properties of the crude substance. Currently, several stakeholders inthe pharmaceutical industry are actively engaged in the efforts to developleads based on natural and synthetic derivatives of cannabinoids.

 

To order this 250+ page report, which features 140+ figuresand 170+ tables, please visit this -https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html

 

The over USD 5 billion (by 2030)financial opportunity within the endocannabinoid system targeted therapeutics market has been analyzed across thefollowing segments:

§ Target Disease Indication

§ Cancer

§ Genetic Disorders

§ Neurological Indications

§ Others

 

§ Route of Administration

§ Oral

§ Inhalation

 

§ Key Geographies

§ North America

§ Europe

Asia-Pacific and theRest of the World

 

The “Endocannabinoid System Targeted Therapeutics Market, 2020-2030" reportfeatures the following companies, which we identified to be key players in thisdomain:

§ GW Pharmaceuticals

§ Corbus Pharmaceuticals

§ Tilray

§ Tetra Bio-Pharma

§ Botanix Pharmaceuticals

§ Kalytera Therapeutics

§ Therapix Biosciences

§ Echo Pharmaceuticals

§ Avicanna

§ GB Sciences

 

Table of Contents

 

1.         PREFACE

 

2.         EXECUTIVE SUMMARY

 

3.         INTRODUCTION

 

4.         MARKET LANDSCAPE: ENDOCANNABINOIDSYSTEM TARGETED THERAPEUTICS

 

5.         COMPANY PROFILES

 

6.         ACADEMIC GRANTS ANALYSIS

 

7.         PARTNERSHIPS AND COLLABORATIONS

 

8.         MERGERS AND ACQUISITIONS

 

9.         DRUG DEVELOPMENT STRATEGY ANALYSIS

10.        MARKET FORECAST AND OPPORTUNITY ANALYSIS

 

11.        CONCLUDING REMARKS

 

12.        EXECUTIVE INSIGHTS

 

13.        APPENDIX 1: TABULATED DATA

 

14.        APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

 

To purchase a copy,please visit https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html

 

Contact Details

GauravChaudhary

+1(415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com